Ország: Egyesült Államok
Nyelv: angol
Forrás: NLM (National Library of Medicine)
AMANTADINE HYDROCHLORIDE (UNII: M6Q1EO9TD0) (AMANTADINE - UNII:BF4C9Z1J53)
Morton Grove Pharmaceuticals, Inc.
Amantadine Hydrochloride
Amantadine Hydrochloride 50 mg in 5 mL
ORAL
PRESCRIPTION DRUG
Amantadine Hydrochloride Oral Solution, USP is indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride is also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. Amantadine hydrochloride is indicated for chemoprophylaxis against signs and symptoms of influenza A virus infection. Because amantadine hydrochloride does not completely prevent the host immune response to influenza A infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses. Following vaccination during an influenza A outbreak, amantadine hydrochloride prophylaxis should be considered for the 2- to 4-week time period required to develop an antibody response. Amantadine hydrochloride is also indicated in the treatment of uncomplicated respiratory tract illness caused by influenza A virus strains e
Amantadine Hydrochloride Oral Solution USP, 50 mg/5 mL is a colorless to pale yellow, raspberry-flavored oral solution available in: 1 Pint (473 mL) bottles NDC 60432-093-16 Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]. KEEP TIGHTLY CLOSED Dispense in a tight container as defined in the USP, with a child-resistant closure (as required). Rx Only
Abbreviated New Drug Application
AMANTADINE HYDROCHLORIDE- AMANTADINE HYDROCHLORIDE SOLUTION MORTON GROVE PHARMACEUTICALS, INC. ---------- AMANTADINE HYDROCHLORIDE ORAL SOLUTION, USP 50 MG/5 ML RX ONLY DESCRIPTION Amantadine hydrochloride, USP is designated chemically as 1-adamantanamine hydrochloride. C10H17N • HCL M.W. 187.71 Amantadine hydrochloride is a stable white or nearly white crystalline powder, freely soluble in water and soluble in alcohol and in chloroform. Amantadine hydrochloride has pharmacological actions as both an anti-Parkinson and an antiviral drug. Amantadine Hydrochloride Oral Solution, USP contains 50 mg of amantadine hydrochloride per 5 mL and has the following inactive ingredients: anhydrous citric acid, artificial raspberry flavor, methylparaben, propylene glycol, propylparaben, purified water, saccharin sodium, sodium citrate dihydrate, and sorbitol solution. CLINICAL PHARMACOLOGY PHARMACODYNAMICS Mechanism of Action _Antiviral_ The mechanism by which amantadine hydrochloride exerts its antiviral activity is not clearly understood. It appears to mainly prevent the release of infectious viral nucleic acid into the host cell by interfering with the function of the transmembrane domain of the viral M2 protein. In certain cases, amantadine hydrochloride is also known to prevent virus assembly during virus replication. It does not appear to interfere with the immunogenicity of inactivated influenza A virus vaccine. _Antiviral Activity_ Amantadine hydrochloride inhibits the replication of influenza A virus isolates from each of the subtypes, i.e., H1N1, H2N2 and H3N2. It has very little or no activity against influenza B virus isolates. A quantitative relationship between the in vitro susceptibility of influenza A virus to amantadine hydrochloride and the clinical response to therapy has not been established in man. Sensitivity test results, expressed as the concentration of amantadine hydrochloride required to inhibit by 50% the growth of virus (ED50) in tissue culture vary greatly (from 0.1 µg/mL to 25.0 µg/mL) depend Olvassa el a teljes dokumentumot